Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
BeOne Medicines
M.D. Anderson Cancer Center
University of Chicago
Eli Lilly and Company
Auron Therapeutics, Inc.
Biomea Fusion Inc.
Pfizer
National Institutes of Health Clinical Center (CC)
Senti Biosciences
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
Jonsson Comprehensive Cancer Center
Washington University School of Medicine
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Beth Israel Deaconess Medical Center
Polaris Group
Byondis B.V.
Dana-Farber Cancer Institute
University of Pennsylvania
Great Ormond Street Hospital for Children NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Acerta Pharma BV
M.D. Anderson Cancer Center
AbbVie
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
Seattle Children's Hospital
University of Pennsylvania
Fate Therapeutics
Thomas Jefferson University
City of Hope Medical Center
City of Hope Medical Center
Miltenyi Biomedicine GmbH
Dana-Farber Cancer Institute
Baylor College of Medicine
National Cancer Institute (NCI)